A clinical case of the new-onset bipolar affective disorder in the postcovid period

S S Korsakov Journal of Neurology and Psychiatry, Год журнала: 2024, Номер 124(3), С. 125 - 125

Опубликована: Янв. 1, 2024

A large number of people who have had COVID-19 developed mental symptoms and mood disorders. Anxiety depression prevail among affective pathology. Evidence is accumulating that the Sars-CoV-2 virus can induce mania or hypomania in with no personal psychopathological history. Some clinical, anamnestic paraclinical patterns new-onset been found. In cases severe manic symptoms, it possible to quickly assume occurrence bipolar disorder. The predominance depressive anxiety syndromes long-term disease presence vivid vegetative mask brief syndromally incomplete episodes hypomania, which distorts understanding as a This article presents such clinical case disorder patient an asymptomatic course. Approaches rational diagnosis treatment are discussed.

Язык: Английский

How to treat major depressive disorder with shorter-duration hypomanic episodes? A case report

Frontiers in Psychiatry, Год журнала: 2024, Номер 15

Опубликована: Июль 15, 2024

Here we report on a case of 61-year-old female patient with 7-year history major depressive disorder shorter-duration hypomanic episodes who was prescribed antidepressants which turned out to be ineffective. After COVID-19 infection, the patient's clinical presentation became sufficient for diagnosis bipolar and she consistently effective mood stabilizer an atypical antipsychotic. The course treatment in this suggests is not binary disorder, but continuous spectrum disorder. For patients suffering from episodes, stabilizers antipsychotics are possibly more suitable than antidepressants.

Язык: Английский

Onset of bipolar disorder by COVID-19: The roles of endogenous ouabain and the Na,K-ATPase

Journal of Psychiatric Research, Год журнала: 2024, Номер 179, С. 60 - 68

Опубликована: Авг. 31, 2024

Язык: Английский